CSIMarket
 


Antares Pharma Inc   (ATRS)
Other Ticker:  
 
 

ATRS's Capital Expenditures Growth by Quarter and Year

Antares Pharma Inc 's Capital Expenditures results by quarter and year




ATRS Capital Expenditures (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 15.47 6.72 1.08
III Quarter September - 2.50 5.45 0.17
II Quarter June - 1.27 1.80 0.71
I Quarter March 0.08 1.18 0.64 0.39
FY   0.08 20.42 14.61 2.35



ATRS Capital Expenditures first quarter 2022 Y/Y Growth Comment
Antares Pharma Inc reported drop in Capital Expenditures in the first quarter 2022 by -93.14% to $ 0.08 millions, from the same quarter in 2021.
The fall in the first quarter 2022 Antares Pharma Inc 's Capital Expenditures compares unfavorably to the Company's average Capital Expenditures doubling of 262.17%.

Looking into first quarter 2022 results within Medical Equipment & Supplies industry 136 other companies have achieved higher Capital Expenditures growth. While Antares Pharma Inc ' s Capital Expenditures meltdown of -93.14% ranks overall at the positon no. 3314 in the first quarter 2022.




ATRS Capital Expenditures ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - 130.21 % 522.22 % 227.27 %
III Quarter September - -54.13 % 3105.88 % -19.05 %
II Quarter June - -29.44 % 153.52 % 153.57 %
I Quarter March -93.14 % 84.38 % 64.1 % 457.14 %
FY   - 39.77 % 521.7 % 164.04 %

Financial Statements
Antares Pharma Inc 's first quarter 2022 Capital Expenditures $ 0.08 millions ATRS's Income Statement
Antares Pharma Inc 's first quarter 2021 Capital Expenditures $ 1.18 millions Quarterly ATRS's Income Statement
New: More ATRS's historic Capital Expenditures Growth >>


ATRS Capital Expenditures (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - 518.8 % 23.3 % 535.29 %
III Quarter September - 96.85 % 202.78 % -76.06 %
II Quarter June - 7.63 % 181.25 % 82.05 %
I Quarter March -99.48 % -82.44 % -40.74 % 18.18 %
FY (Year on Year)   - 39.77 % 521.7 % 164.04 %




Capital Expenditures first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #137
Healthcare Sector #616
Overall #3314

Capital Expenditures Y/Y Growth Statistics
High Average Low
3105.29 % 262.17 % -93.16 %
(Sep 30 2020)   (Mar 31 2022)
Capital Expenditures first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #137
Healthcare Sector #616
Overall #3314
Capital Expenditures Y/Y Growth Statistics
High Average Low
3105.29 % 262.17 % -93.16 %
(Sep 30 2020)   (Mar 31 2022)

Capital Expenditures by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Antares Pharma Inc 's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
5696.81 % 233.46 % -100 %
(Sep 30 2020)  


ATRS's I. Quarter Q/Q Capital Expenditures Comment
In the I. Quarter 2022 Antares Pharma Inc disclosed fall in Capital Expenditures from the previous quarter by -99.48% to $ 0.08 millions, from $ 15.47 millions declared in the previous reporting period.

When you evaluate recent slump in the quarter, you must presume, that frequently I. Quarter 2022 results emerge weaker in contrast to the quarter before

Within Medical Equipment & Supplies industry 159 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Antares Pharma Inc 's Capital Expenditures growth quarter on quarter, overall rank is 3667.


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #160
Healthcare Sector #749
Overall #3667
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #160
Healthcare Sector #749
Overall #3667
Capital Expenditures Q/Q Growth Statistics
High Average Low
5696.81 % 233.46 % -100 %
(Sep 30 2020)  


ATRS's I. Quarter Q/Q Capital Expenditures Comment
In the I. Quarter 2022 Antares Pharma Inc realized fall in Capital Expenditures from the fourth quarter by -99.48% to $ 0.08 millions, from $ 15.47 millions declared a quarter before.

As we look into current slump in the I. Quarter 2022, we should assume, that commonly I. Quarter 2022 results appear to be sluggish in contrast to the quarter before, Anvi Dasgupta , Medical Equipment & Supplies industry veteran allocated in Bengaluru said.

Within Medical Equipment & Supplies industry 159 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Antares Pharma Inc 's Capital Expenditures growth quarter on quarter, overall rank is 3667.


Antares Pharma Inc 's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
Cumulative Capital Expenditures 12 Months Ending $ 19.33 $ 20.43 $ 11.68 $ 14.63 $ 15.16
Y / Y Capital Expenditures Growth (TTM) 27.52 % 39.8 % 30.25 % 296.42 % 483 %
Year on Year Capital Expenditures Growth Overall Ranking # 1245 # 1167 # 920 # 123 # 605
Seqeuential Capital Expenditures Change (TTM) -5.4 % 74.9 % -20.14 % -3.5 % 3.72 %
Seq. Capital Expenditures Growth (TTM) Overall Ranking # 2011 # 234 # 2812 # 2138 # 1869




Cumulative Capital Expenditures growth Comment
With the quarterly Capital Expenditures reported in the Mar 31 2022 period, Antares Pharma Inc 's cumulative twelve months Capital Expenditures were $ 19 millions, company would post below average annual Capital Expenditures growth of 3.72% year on year, if the fiscal year would end at Mar 31 2022.
A slow-down in the Antares Pharma Inc 's Capital Expenditures growth from the 15.47% growth in Dec 31 2021.

In the Healthcare sector 220 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Capital Expenditures growth total ranking has deteriorated compare to previous quarter from 1167 to 1245.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
797.09 %
93.34 %
-109.99 %
 

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 97
Healthcare Sector # 221
Overall # 1245

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
797.09 %
93.38 %
-81.26 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 97
Sector # 341
S&P 500 # 2011
Cumulative Capital Expenditures growth Comment
With the quarterly Capital Expenditures reported in the Mar 31 2022 period, Antares Pharma Inc 's cumulative twelve months Capital Expenditures were $ 19 millions, company would post below average annual Capital Expenditures growth of -81.26% year on year, if the fiscal year would end at Mar 31 2022.
A slow-down in the Antares Pharma Inc 's Capital Expenditures growth from the 15.47% growth in Dec 31 2021.

In the Healthcare sector 220 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Capital Expenditures growth total ranking has deteriorated compare to previous quarter from 1167 to 1245.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
797.09 %
93.34 %
-109.99 %
 


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 97
Healthcare Sector # 221
Overall # 1245

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
797.09 %
93.38 %
-81.26 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 97
Sector # 341
S&P 500 # 2011




Other Capital Expenditures Growth
Medical Equipment & Supplies Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
ATRS's Capital Expenditures Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for ATRS's Competitors
Capital Expenditures Growth for Antares Pharma Inc 's Suppliers
Capital Expenditures Growth for ATRS's Customers

You may also want to know
ATRS's Annual Growth Rates ATRS's Profitability Ratios ATRS's Asset Turnover Ratio ATRS's Dividend Growth
ATRS's Roe ATRS's Valuation Ratios ATRS's Financial Strength Ratios ATRS's Dividend Payout Ratio
ATRS's Roa ATRS's Inventory Turnover Ratio ATRS's Growth Rates ATRS's Dividend Comparisons



Companies with similar Capital Expenditures fall for the quarter ending Mar 31 2022 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Mar 31 2022
Novan Inc -0.64%$ -0.642 millions
Brookdale Senior Living Inc -1.00%$ -1.003 millions
Steris Plc-2.26%$ -2.264 millions
Alkermes Plc -2.44%$ -2.442 millions
Novabay Pharmaceuticals Inc -4.00%$ -4.000 millions
Shattuck Labs Inc -5.69%$ -5.686 millions
Morphic Holding inc -5.88%$ -5.882 millions
Fulcrum Therapeutics Inc -6.11%$ -6.107 millions
Vbi Vaccines Inc-7.37%$ -7.374 millions
Community Health Systems Inc -7.62%$ -7.619 millions
Sqz Biotechnologies Company-7.69%$ -7.692 millions
Tarsus Pharmaceuticals Inc -8.00%$ -8.000 millions
Inspire Medical Systems inc -8.02%$ -8.024 millions
Becton Dickinson And Company-10.28%$ -10.277 millions
Vertex Pharmaceuticals Inc-10.33%$ -10.329 millions
Xtant Medical Holdings Inc -10.70%$ -10.701 millions
Myriad Genetics Inc -11.27%$ -11.268 millions
Exact Sciences Corporation-11.33%$ -11.332 millions
Inogen Inc -11.41%$ -11.414 millions
Alphatec Holdings Inc -11.81%$ -11.808 millions
Avanos Medical Inc -12.28%$ -12.281 millions
Merck and Co Inc -13.23%$ -13.228 millions
Genocea Biosciences Inc -13.35%$ -13.345 millions
Abbvie inc -13.83%$ -13.830 millions
Acadia Healthcare Company Inc -13.90%$ -13.897 millions
Procyon Corporation-14.32%$ -14.319 millions
Ocugen Inc -14.56%$ -14.559 millions
Therapeutic Solutions International Inc -14.97%$ -14.974 millions
Davita Inc -15.05%$ -15.047 millions
Biolife Solutions Inc -15.35%$ -15.349 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com